German Healthtech Stock News

Rheinmetall (XTRA:RHM) is back in focus after rising interest in defense stocks tied to recent geopolitical tensions, including US activity around Venezuela and an incident involving a Russian oil tanker. See our latest analysis for Rheinmetall. The recent geopolitical headlines seem to have fed into Rheinmetall’s momentum, with a 7 day share price return of 9.28% and a 30 day share price return of 17.70% on the way to a year to date gain of 18.73%. Meanwhile, the 1 year total shareholder...

In recent days, analysts have reiterated strong confidence in LEG Immobilien SE, highlighting its transition toward a scaled, platform-style housing operator focused on efficiency, affordability, and ESG-oriented energy upgrades under Germany’s tight regulatory framework. What stands out is the combination of a strong buy analyst consensus and increased insider buying, suggesting that both external analysts and internal stakeholders see the company’s platform model and operational resilience...

Evotec SE recently entered a five-year multi-component alliance with Sanofi, featuring a minimum guaranteed commitment of €250 million and an upfront payment of more than €40 million, while also appointing Dr. Sarah Fakih as Executive Vice President, Head of Global Communications and Investor Relations to integrate its communications and investor outreach. The combination of a large, multi-year Sanofi commitment across Evotec’s Execute and Innovate segments and a strengthened investor...

Recognition from Wells Fargo as its preferred software name, new AI products for retail, deeper AI use in consulting with KPMG, and fresh regional leadership have put SAP (XTRA:SAP) firmly in focus for investors. See our latest analysis for SAP. These AI announcements and the recognition from Wells Fargo come as SAP trades at €213.1, with a 7 day share price return of 3.35% and a year to date share price return of 5.52%. The 1 year total shareholder return of an 11.84% decline contrasts with...

Key Insights KION GROUP's estimated fair value is €121 based on 2 Stage Free Cash Flow to Equity KION GROUP's €65.60...

With a median price-to-earnings (or "P/E") ratio of close to 18x in Germany, you could be forgiven for feeling...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Those branded calling launches with Hiya and First Orion put Deutsche Telekom (XTRA:DTE) right in the middle of efforts to make mobile voice more trusted, which is where today’s stock discussion starts. See our latest analysis for Deutsche Telekom. The branded calling partnerships arrive during a period of gradually improving share price sentiment, with a 7-day share price return of 4.44% and a 30-day share price return of 7.01% partially offsetting a 90-day share price decline of 2.58%. The...

Investor attention around Siemens Energy (XTRA:ENR) has picked up as the company prepares to present at the German Investment Seminar in New York on January 12, 2026. CFO and Executive Board member Maria Ferraro will be speaking. See our latest analysis for Siemens Energy. Against this backdrop, Siemens Energy’s €128.20 share price sits after a 1 day share price return of 1.87% and a 90 day share price return of 20.77%. The 1 year total shareholder return of 160.41% and very large 3 year...

In the past year, Germany’s Merck KGaA reported that its 2014 group sales rose 3.7%, while fourth-quarter EBITDA excluding one-offs increased 10.5%, both ahead of analyst forecasts. This stronger-than-expected revenue and earnings performance highlighted Merck KGaA’s operational discipline and demand resilience across its core science and technology businesses. We’ll now examine how this earnings beat, particularly the stronger fourth-quarter profitability, could influence Merck KGaA’s...

Uniper recently announced a long‑term binding offtake agreement with AM Green Ammonia India to purchase up to 500,000 tons of RFNBO-certified renewable ammonia annually from projects in India, with first shipments targeted from a Kakinada plant as early as 2028. This deal not only supports industrial decarbonization in Europe but also helps establish India as an emerging export hub for large-scale green ammonia supply. We’ll now examine how this long-term green ammonia offtake agreement...

Key Insights tonies' significant private equity firms ownership suggests that the key decisions are influenced by...

Key Insights The considerable ownership by retail investors in HomeToGo indicates that they collectively have a greater...

IBU-tec advanced materials AG's ( ETR:IBU ) price-to-sales (or "P/S") ratio of 2.3x may not look like an appealing...

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...

Hensoldt AG ( ETR:HAG ) shareholders are no doubt pleased to see that the share price has bounced 26% in the last...

Key Insights Berliner Effektengesellschaft's significant insider ownership suggests inherent interests in company's...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Key Insights The projected fair value for Edel SE KGaA is €5.87 based on 2 Stage Free Cash Flow to Equity With €5.05...

Singulus Technologies AG ( ETR:SNG ) shares have had a really impressive month, gaining 28% after a shaky period...

FRIWO AG ( ETR:CEA ) shareholders are no doubt pleased to see that the share price has bounced 26% in the last month...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Fresenius Medical Care recently decided to accelerate its existing €1.00 billion share buyback program, launching a second tranche of around €415 million from January 12 to May 8, 2026, after completing the first tranche early in December 2025. This faster pace of repurchases, backed by management’s confidence in the business and framed within the “FME Reignite” value-creation plan, meaningfully increases the company’s near‑term focus on returning capital to shareholders. We’ll now examine...